2008
DOI: 10.1016/j.tim.2008.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Mycobacterial glycoconjugates as vaccine candidates against tuberculosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
38
0
1

Year Published

2009
2009
2017
2017

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 42 publications
(40 citation statements)
references
References 75 publications
0
38
0
1
Order By: Relevance
“…2, 3 The glycosylation or other controlled chemical modications of proteins, such as PEGylation and acylation, can dramatically improve their physical and biological properties. 4 For instance, chemical conjugation with suitable glycans has been exploited for the production of therapeutic enzymes with improved activity and reduced in vivo metabolism.…”
Section: Introductionmentioning
confidence: 99%
“…2, 3 The glycosylation or other controlled chemical modications of proteins, such as PEGylation and acylation, can dramatically improve their physical and biological properties. 4 For instance, chemical conjugation with suitable glycans has been exploited for the production of therapeutic enzymes with improved activity and reduced in vivo metabolism.…”
Section: Introductionmentioning
confidence: 99%
“…They play a role in biological recognition phenomena involving cells and proteins. Moreover, oligosaccharides are present in the form of lectins in all cell walls mediating a variety of events such as inflammation, cell-cell recognition, immunological response, metastasis, and fertilization (31,32). In the food industry, calcium binding marine food-derived lectins can be incorporated in nutraceutical or functional food to prevent calcium deficiency.…”
Section: Potential Functional Ingredients From Marine Productsmentioning
confidence: 99%
“…In preclinical animal experiments they proved to be highly efficient in protection against experimental challenge with virulent Mtb, both in terms of reduced pathology and long time survival which was equal to or slightly better than that conferred by conventional BCG vaccination. 48,63 Of particular interest is the finding that the AM oligosaccharde-tetanus toxoid (the heterologous carrier protein unrelated to Mtb) conjugate vaccine afforded significant protection. This provided the proof of principle that immunity elicited by a carbohydrate antigen alone can confer protective immunity against TB Hence, mycobacterial carbohydrates are important candidate antigens which should be included in a forthcoming new vaccine.…”
Section: Mycobacterial Carbohydrate Antigen-based Vaccine Candidatesmentioning
confidence: 99%